Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b-Reference-Cited by-同舟云学术

Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b

Published:2011-03-01 Issue:2 Volume:19 Page:120-127
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:

Author:

Vermehren J.,Susser S.,Lange C. M.,Forestier N.,Karey U.,Hughes E.,Ralston R.,Tong X.,Zeuzem S.,Sarrazin C.

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2011.01449.x/fullpdf

Reference28 articles.

1. World Health Organization Hepatitis C Virus http://www.who.int/vaccine_research/diseases/viral_cancers/en/index2.html

2. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

4. Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial;Kwo;Lancet,2010

5. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection;Hezode;N Engl J Med,2009

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs;Viruses;2021-06-16

2. Treatment failure with DAA therapy: Importance of resistance;Journal of Hepatology;2021-06

3. Resistance mutations of NS3 and NS5b in treatment-naïve patients infected with hepatitis C virus in Santa Catarina and Rio Grande do Sul states, Brazil;Genetics and Molecular Biology;2020

4. Full-Genome Analysis of Hepatitis C Virus in Japanese and Non-Japanese Patients Coinfected With HIV-1 in Tokyo;JAIDS Journal of Acquired Immune Deficiency Syndromes;2019-03-01

5. Prevalence of hepatitis C virus-resistant association substitutions to direct-acting antiviral agents in treatment-naïve hepatitis C genotype 1b-infected patients in western China;Infection and Drug Resistance;2017-10